Coronavirus disease 2019 in elderly patients: Characteristics and prognostic factors based on 4-week follow-up
- PMID: 32240670
- PMCID: PMC7118526
- DOI: 10.1016/j.jinf.2020.03.019
Coronavirus disease 2019 in elderly patients: Characteristics and prognostic factors based on 4-week follow-up
Abstract
Objective: To investigate the characteristics and prognostic factors in the elderly patients with COVID-19.
Methods: Consecutive cases over 60 years old with COVID-19 in Renmin Hospital of Wuhan University from Jan 1 to Feb 6, 2020 were included. The primary outcomes were death and survival till March 5. Data of demographics, clinical features, comorbidities, laboratory tests and complications were collected and compared for different outcomes. Cox regression was performed for prognostic factors.
Results: 339 patients with COVID-19 (aged 71±8 years,173 females (51%)) were enrolled, including 80 (23.6%) critical, 159 severe (46.9%) and 100 moderate (29.5%) cases. Common comorbidities were hypertension (40.8%), diabetes (16.0%) and cardiovascular disease (15.7%). Common symptoms included fever (92.0%), cough (53.0%), dyspnea (40.8%) and fatigue (39.9%). Lymphocytopenia was a common laboratory finding (63.2%). Common complications included bacterial infection (42.8%), liver enzyme abnormalities (28.7%) and acute respiratory distress syndrome (21.0%). Till Mar 5, 2020, 91 cases were discharged (26.8%), 183 cases stayed in hospital (54.0%) and 65 cases (19.2%) were dead. Shorter length of stay was found for the dead compared with the survivors (5 (3-8) vs. 28 (26-29), P < 0.001). Symptoms of dyspnea (HR 2.35, P = 0.001), comorbidities including cardiovascular disease (HR 1.86, P = 0.031) and chronic obstructive pulmonary disease (HR 2.24, P = 0.023), and acute respiratory distress syndrome (HR 29.33, P < 0.001) were strong predictors of death. And a high level of lymphocytes was predictive of better outcome (HR 0.10, P < 0.001).
Conclusions: High proportion of severe to critical cases and high fatality rate were observed in the elderly COVID-19 patients. Rapid disease progress was noted in the dead with a median survival time of 5 days after admission. Dyspnea, lymphocytopenia, comorbidities including cardiovascular disease and chronic obstructive pulmonary disease, and acute respiratory distress syndrome were predictive of poor outcome. Close monitoring and timely treatment should be performed for the elderly patients at high risk.
Keywords: Coronavirus infections; Pneumonia; Prognosis; SARS-CoV-2.
Copyright © 2020. Published by Elsevier Ltd.
Conflict of interest statement
Declaration of Competing Interest The authors declare that there is no conflict of interests.
Figures


Comment in
-
Clinical features of 95 sequential hospitalised patients with novel coronavirus 2019 disease (COVID-19), the first UK cohort.J Infect. 2020 Aug;81(2):e59-e61. doi: 10.1016/j.jinf.2020.04.020. Epub 2020 Apr 27. J Infect. 2020. PMID: 32353384 Free PMC article. No abstract available.
-
Comparison of short-term mortality between mechanically ventilated patients with COVID-19 and influenza in a setting of sustainable healthcare system.J Infect. 2020 Aug;81(2):e76-e78. doi: 10.1016/j.jinf.2020.05.005. Epub 2020 May 8. J Infect. 2020. PMID: 32423535 Free PMC article. No abstract available.
-
The effects of the COVID-19 virus on mental healthcare for older people in The Netherlands.Int Psychogeriatr. 2020 Nov;32(11):1353-1356. doi: 10.1017/S1041610220001040. Epub 2020 Jun 3. Int Psychogeriatr. 2020. PMID: 32491980 Free PMC article. No abstract available.
-
Hepatic manifestations and complications of COVID-19: A systematic review and meta-analysis.J Infect. 2020 Sep;81(3):e72-e74. doi: 10.1016/j.jinf.2020.06.043. Epub 2020 Jun 21. J Infect. 2020. PMID: 32579984 Free PMC article. No abstract available.
-
Outbreak of COVID-19 in a nursing home in Madrid.J Infect. 2020 Oct;81(4):647-679. doi: 10.1016/j.jinf.2020.06.055. Epub 2020 Jun 25. J Infect. 2020. PMID: 32592704 Free PMC article. No abstract available.
-
Clinical characteristics and outcome of COVID-19 pneumonia in elderly subjects.J Infect. 2021 Feb;82(2):e33-e34. doi: 10.1016/j.jinf.2020.08.023. Epub 2020 Aug 19. J Infect. 2021. PMID: 32827588 Free PMC article. No abstract available.
-
Increased number of prostate cancer patients selecting high dose-rate interstitial brachytherapy during the COVID-19 pandemic.Radiother Oncol. 2021 Jan;154:274-275. doi: 10.1016/j.radonc.2020.11.015. Epub 2020 Nov 21. Radiother Oncol. 2021. PMID: 33227353 Free PMC article. No abstract available.
References
-
- 6th Ed. National Health Commision of the People's Republic of China; 2020. Interim guidance for novel coronavirus pneumonia.http://www.nhc.gov.cn/yzygj/s7653p/202002/8334a8326dd94d329df351d7da8aef... Accessed February 27th, 2020.
-
- Report of the WHO-China Joint Mission on Coronavirus Disease . 2019. https://www.who.int/docs/default-source/coronaviruse/who-china-joint-mis... Accessed Mar 5th, 2020.
-
- Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract. 2012;120(4):c179–c184. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous